Connect with Us at the Upcoming Events

With in-person events back again, Creative Biolabs is excited to greet you at the upcoming international conferences. Meet our team at 2022 BIO International Convention in June (booth #1754) and at the 13th Annual World ADC San Diego in September (booth number to be updated) for expert consultation on your drug discovery. Shoot an email to arrange an in-person meeting!

Book a Meeting

Embryonic Stem Cells-based Therapy Development

Creative Biolabs is an experienced and excellent provider of data validation and project evaluation for stem cell therapy. We are committed to providing comprehensive project management and high-quality data verification services for your stem cell therapy project. We are pleased to use our extensive experience and advanced platform to provide the best services to meet every need of our customers.

What Are Embryonic Stem Cells (ESCs)?

ESCs are pluripotent stem cells that are derived from the inner cell mass of a blastocyst, an early-stage preimplantation embryo. They are taken from embryos in a very early stage of development and have two important properties: they have the ability to replicate infinitely through simple division (self-renewal) and to differentiate into any cell type (pluripotency) in the human body. These characteristics not only open up new prospects for regenerative medicine but also for the study of genetic diseases and the development of new treatments.

ESCs Therapy

Due to their plasticity and potentially unlimited capacity for self-renewal, ESCs therapy offers great promise for new medical treatments. This technology involves obtaining healthy and functional specialized cells from ESCs, then injecting them into a patient to regenerate an organ or restore organ function. ESCs have been proposed for treating intractable diseases such as diabetes, spinal cord injuries, neurodegenerative and cardiovascular diseases. ESC therapy can be used to regenerate organs or produce substances necessary to restore biological functions. However, translating the potential of ESCs into treatments has been challenging because of the safety and technical issues.

Challenges in ESCs Therapy

The two main challenges in the translation of ESCs to clinical applications are teratoma formation by residual undifferentiated ESCs in the cell preparation and immune rejection of ESC-derived cells or tissues due to incompatible HLA profiles of ESC and recipient (Fig.1).

Embryonic Stem Cells-based Therapy Development Fig.1 Reduce tumor formation and immune rejection. (Yeo, 2011)

Our Service for ESCs Therapy Verification

To ensure the authenticity and accuracy of the data in your stem cell therapy project, we provide accurate and cost-effective data verification and data validation services. Our highly skilled and experienced data verification team can help you keep your data consistent and authenticate. Creative Biolabs can perform any scale data verification or validation project that covers all stages of stem cell therapy development. In addition, to meet the challenging requirements, we provide comprehensive project solutions and expert consultation for your scientific research, including but not limited to:

At Creative Biolabs, all projects are worth considering, regardless of size or complexity. With abundant experience in stem cell research, our scientists are dedicated to fulfilling your data validation needs and addressing any challenges in stem cell therapy development. If you have any questions about our ESCs services, please feel free to contact us.

Reference

  1. Yeo, R. W. Y.; Lim, S. K. Embryonic stem cells for therapies-challenges and possibilities. Embryonic Stem Cells-Basic Biology to Bioengineering. 2011.
For Research Use Only

Let's Get Started

Contact Us

USA

UK

Follow us on

Copyright © 2022 Creative Biolabs. All Rights Reserved.